AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Enclosing copies of the Notice of Hearing of Petition published in Newspapers19-08-2023
19-08-2023
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find attached the earning call transcript for the quarter ended June 30, 2023.18-08-2023
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached copies of the notice published in newspapers.18-08-2023
AUROBINDO PHARMA LTD. - 524804 - Advisory Letter Under SEBI (LODR) Regulations, 2015 Dated June 14, 2023, Received From National Stock Exchange Of India Limited.
The Board of Directors took note of the Advisory Letter.17-08-2023
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform that the officials of the Company will be participating in the investor / analyst meeting on August 23, 2023.17-08-2023
AUROBINDO PHARMA LTD. - 524804 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We bring to your kind notice that the Company letters from the shareholders informing about the loss of share certificates.17-08-2023
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform that the officials of the Company will be participating in the investor / analyst meeting on August 22, 2023.17-08-2023
Accumulate Aurobindo Pharma; target of Rs 900: Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 900 in its research report dated August 14, 2023.16-08-2023
AUROBINDO PHARMA LTD. - 524804 - Addendum To The 36Th Annual General Meeting Of The Company.
Please find attached the Addendum to the 36th Annual General Meeting to be held on August 25, 2023 at 3.30 P.M. IST16-08-2023
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
We enclose a copy of the press release being issued by the Company in connection with launch of HIV triple combination products for children living with HIV.16-08-2023